Oppenheimer Asset Management Inc. Charles River Laboratories International, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $8.04 Billion
- Q3 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 46,556 shares of CRL stock, worth $7.72 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
46,556
Previous 47,545
2.08%
Holding current value
$7.72 Million
Previous $9.82 Million
6.62%
% of portfolio
0.11%
Previous 0.13%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
693Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$844 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$620 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$353 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$322 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.44B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...